1. Home
  2. SCD vs ANL Comparison

SCD vs ANL Comparison

Compare SCD & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

HOLD

Current Price

$14.84

Market Cap

356.2M

Sector

Finance

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$7.10

Market Cap

293.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCD
ANL
Founded
2003
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
356.2M
293.4M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SCD
ANL
Price
$14.84
$7.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
37.5K
196.2K
Earning Date
01-01-0001
04-20-2026
Dividend Yield
9.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.35
$0.88
52 Week High
$16.89
$12.09

Technical Indicators

Market Signals
Indicator
SCD
ANL
Relative Strength Index (RSI) 29.14 39.77
Support Level $14.65 $1.36
Resistance Level $15.11 $9.98
Average True Range (ATR) 0.33 0.89
MACD -0.09 -0.33
Stochastic Oscillator 0.79 13.03

Price Performance

Historical Comparison
SCD
ANL

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: